// App-Quantinova.ai

: The new prognostic index of advanced gastric cancer using the data from JCOG1013.

Researchers

Presenter

  • Daisuke Takahari

Principal Investigators

  • Narikazu Boku

  • Satoru Iwasa

  • Junki Mizusawa

  • Tadayoshi Hashimoto

  • Takaki Yoshikawa

  • Shigenori Kadowaki

  • Nozomu Machida

  • Kenji Ishido

  • Masahiro Tsuda

  • Takahiro Kinoshita

  • Takushi Yasuda

  • Keisho Chin

  • Hiroaki Hata

  • Toshiyasu Ojima

  • Yasuhide Yamada

  • Masanori Terashima

Medical Centers

  • Department of Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan

  • Department of Pharmacy,The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

  • Shizuoka Cancer Center, Department of Gastric Surgery, Sunto-Gun, Japan

  • Comprehensive Cancer Center, National Center for Global Health and Medicine, Tokyo, Japan

  • Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan

  • Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan

  • Department of Gynecology, Kitasato University School of Medicine, Sagamihara, Japan

  • JCOG Data Center/ Operation Office, National Cancer Center Hospital, Tokyo, Japan

  • Japan Clinical Oncology Group Data Center, National Cancer Center, Tokyo, Japan

  • Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan

  • Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

  • Department of Gastric Surgery, National Cancer Center Hospital Japan East, Kashiwa, Japan

  • Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

  • Second Department of Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan

  • Department of Surgery, Kinki University Faculty of Medicine, Osaka-Sayama, Osaka, Japan

  • Department of Surgery, National Hospital Organization Kokura Medical Center, Kitakyushu City, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Cisplatin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • III

Study Id's

  • JCOG1013

  • JCOG9912

Sponsors

  • N/A

Result

  • N/A